Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with CELG as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|8.27%||Merrill Lynch Biotech HOLDRS (BBH)||+22.44 (28.59%)|
|7.51%||iShares NASDAQ Biotechnology Index Fund (IBB)||+59.67 (29.62%)|
|4.82%||PowerShares Dynamic Pharmaceuticals (PJP)||+13.07 (28.23%)|
|3.12%||Select Sector SPDR Fund - Health Care (XLV)||+8.61 (16.89%)|
|2.92%||iShares Dow Jones U.S. Health Care Index Fund (IYH)||+18.61 (17.37%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Celgene Corporation, together with its subsidiaries (collectively “we,” “our,” “us,” “Celgene” or the “Company”), is a global biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. We are dedicated to innovative research and development designed to bring new therapies to market and we are involved in research in several scientific areas that may deliver proprietary next-generation therapies, targeting areas including intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. Celgene Corporation was incorporated in the State of Delaware in 1986. ... More ...
|Annual EPS Est:||$5.36|
|Quarterly EPS Est:||1.43|